If you’ve recently received a US patent, you may have noticed a glossy ceremonial copy in your mailbox. But starting March 9, 2026, that keepsake will only arrive if you ask for it. The US Patent and Trademark Office (USPTO) is changing how it handles ceremonial copies of electronic patent grants Continue Reading
Highlights and Shortfalls of Recent PBM Legislation
There have been a series of court cases and federal legislation targeting the spread pricing model often used by pharmacy benefit managers (PBM). Spread pricing involves two points of time in prescription drug transactions. First, PBMs negotiate discounts with manufacturers for prescription drugs Continue Reading
Coming to America (the Government Contracting Edition): Ownership, Compliance, and Shifting Policy
Closing the Gap: New Jersey’s New Guardianship Law Smooths the Path to Adulthood for Vulnerable Youth
NJ Law Journal publishes an article Abbey Horwitz authored on New Jersey’s new guardianship law. New Jersey recently enacted a new guardianship law designed to help vulnerable youth transition into adulthood more smoothly. Under the updated law, parents and other interested parties can now begin Continue Reading
‘Berk v. Choy’ and the Evolving Gatekeeper Function of Federal Courts
In a unanimous decision that surely will recalibrate the balance of power between state gatekeeping statutes and federal pleading standards, the U.S. Supreme Court issued Berk v. Choy, 607 U.S. ___ (2026) on Jan. 20, 2026. There, the court held that Delaware’s “affidavit of merit” Continue Reading
One Month of Indiana’s Consumer Data Privacy Law . . . Where Do You Stand on Compliance?
Enforcement of the Indiana Consumer Data Protection Act (CDPA) has begun, and its penalties can add up quickly. The CDPA was signed in 2023 and became effective January 1, 2026. The law governs how covered businesses collect, use, disclose, store, and analyze “personal data,” i.e., nonpublic Continue Reading
FDA Modernizes Draft Guidance on Statistical Methods to Support Clinical Trial Data
Consistent with the Food and Drug Administration’s (FDA) commitment to streamlining the prescription drug and biologics approval processes by adopting innovative approaches to clinical trial design, the agency recently published its draft guidance for industry, “Use of Bayesian Methodology in Continue Reading
Abusive Images Are Posted on an Online Platform—Now What?
A horrific new story hits our feeds every day. Social media platforms and other online spaces are drowning in a flood of abusive generative artificial intelligence (GenAI) content. Like with anything on the internet, users are creating a broad range of content, from entertaining to endearing and Continue Reading
Lack of Justifiable Reliance as the Deciding Factor in M&A Fraud Claims: Lessons From ‘Paragon Metals’
Introduction In Paragon Metals Holdings v. Smith, C.A. No. N21C-12-090-SKR-CCLD (Del. Super. Aug. 13, 2025), the Delaware Superior Court, through its Complex Commercial Litigation Division, resolved claims relating to alleged fraud in connection with the 2018 purchase of Paragon Metals LLC Continue Reading
Will Streamlined Patent Claims Lead to Streamlined Examination? For Now, the Patent Office Says Yes
The patent examination process can often take far too long, and the United States Patent and Trademark Office (USPTO) is determined to do something about it in 2026. This past October, the USPTO started a one-year pilot program to expedite the patent examination process for patent applications with Continue Reading